Abuse of prescription drugs and of illicit drugs has been declared a "national emergency" [1]. This crisis includes the misuse and abuse of cannabinoids, opioids, tranquilizers, stimulants, inhalants, and other types of psychoactive drugs, which statistical analysis documents as a rising trend in the United States. The most recent reports from the National Survey on Drug Use and Health (NSDUH) [2] estimate that 10.6% of the total population of people ages 12 years and older (i.e., about 28.6 million people) misused illicit drugs in 2016, which represents an increase of 0.5% since 2015 [3]. According to the Centers for Disease Control and Prevention (CDC), opioid drugs were involved in 42,249 known deaths in 2016 nationwide [4]. In addition, the number of heroin-involved deaths has been increasing sharply for 5 years, and surpassed the number of firearm homicides in 2015 [5]. In April 2017, the Department of Health and Human Services announced their "Opioid Strategy" to battle the country's drug-abuse crisis [1]. In the Opioid Strategy, one of the major aims is to strengthen public health data collection, to inform a timeliness